Allergan Aesthetics Advances Skin Longevity Science Research

Irvine, California, U.S., September 15, 2026

Skin Longevity and Aging Biology Take Center Stage

The summit program will explore the hallmarks of aging and their relevance to skin biology, with Allergan Aesthetics scientific leaders participating in discussions focused on how advances in aging research could inform future skincare innovation. The company said its participation is intended to promote evidence-based scientific dialogue around skin longevity and regenerative aesthetics. Stephanie Manson Brown, M.D., vice president and head of clinical development, scientific innovation and skincare research and development at Allergan Aesthetics, is scheduled to present on frameworks for targeting the hallmarks of aging and participate in a panel examining longevity science. These discussions are expected to address how greater understanding of biological aging may contribute to new approaches for supporting skin health and appearance over time. Allergan Aesthetics said its skincare research experience includes more than 25 years of research, more than 200 clinical studies, numerous granted U.S. patents, and more than 100 peer-reviewed publications. The company plans to bring this research background to discussions at the summit, with an emphasis on translating scientific understanding into skincare innovation.

FACTS Principles Address Exosome Skincare Science

A key feature of the company’s participation will be a SkinMedica® R&D panel focused on exosome science in skincare. During the session, the company will introduce the FACTS Principles, a framework developed by SkinMedica to encourage more consistent scientific evaluation of exosome-based skincare technologies. The framework is intended to address several scientific considerations, including formulation and stability, analytical testing, clinical studies, cellular origin, and safety. The growing interest in topical exosomes and regenerative aesthetics has created demand for greater scientific understanding of how these technologies are sourced, formulated, preserved, and evaluated. Allergan Aesthetics said the FACTS Principles are intended to encourage more consistent scientific dialogue and transparency across this developing skincare category. The company emphasized that evaluating a biological skincare technology involves more than simply reviewing an ingredient list, with factors such as biological activity and stability within the final formulation also requiring consideration.

Scientific Education Supports Responsible Innovation

Beyond the exosome-focused discussion, Allergan Aesthetics and SkinMedica teams will participate in sessions covering skin biology, regenerative aesthetics, longevity science, barrier renewal, and changing approaches to skincare. The company will also provide educational resources at its exhibition booth during the summit, allowing attendees to engage with scientific information related to emerging skincare technologies. The company’s participation reflects the expanding scientific interest in skin aging and longevity-focused skincare. As research continues to investigate the biological processes underlying aging, the industry is increasingly examining how evidence from cellular and molecular science can inform cosmetic and aesthetic products. The discussions at the 2026 Science of Skin Summit are positioned around improving scientific understanding and encouraging evidence-based innovation in skincare and regenerative aesthetics.

For the broader cosmetics and skincare sector, greater attention to scientific validation, formulation stability, safety, clinical evidence, and biological mechanisms could contribute to more consistent evaluation of emerging technologies. Allergan Aesthetics’ participation at the summit therefore highlights the industry’s continuing movement toward research-driven skincare development and a deeper scientific understanding of skin longevity and aging biology.

Source: Allergan Aesthetics press release